BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/21/2021 6:41:08 AM | Browse: 459 | Download: 1270
 |
Received |
|
2020-10-22 13:10 |
|
Peer-Review Started |
|
2020-10-22 13:11 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-12-03 18:13 |
|
Revised |
|
2020-12-30 13:21 |
|
Second Decision |
|
2021-04-08 12:36 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-04-08 16:20 |
|
Articles in Press |
|
2021-04-08 16:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-05-07 15:12 |
|
Publish the Manuscript Online |
|
2021-06-21 06:41 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Minireviews |
| Article Title |
Review of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Kashif Asghar, Asim Farooq, Bilal Zulfiqar and Asif Loya |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Kashif Asghar, DVM, PhD, Research Scientist, Department of Basic Science Research, Shaukat Khanum Memorial Cancer Hospital and Research Centre 7A, Block R3, Johar Town, Lahore 54000, Pakistan. drkashifasghar@gmail.com |
| Key Words |
Indoleamine 2, 3-dioxygenase; Breast cancer; Therapeutic target; Prognostic marker; Immune responses; Immune escape |
| Core Tip |
Indoleamine 2,3-dioxygenase might be utilized as a potential biomarker and immunotherapeutic target in breast cancer patients. |
| Publish Date |
2021-06-21 06:41 |
| Citation |
Asghar K, Farooq A, Zulfiqar B, Loya A. Review of 10 years of research on breast cancer patients: Focus on indoleamine 2, 3-dioxygenase. World J Clin Oncol 2020; 12(6): 429-436 |
| URL |
https://www.wjgnet.com/2218-4333/full/v12/i6/429.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v12.i6.429 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
